CAS9 Technology Market Overview The global CAS9 technology market, a segment of the broader CRISPR gene-editing field, is projected to grow from USD 3.96 billion in 2024 to a significantly larger market driven by the expanding adoption of gene therapy, biotech, pharmaceutical, and research applications. CAS9 is at the heart of CRISPR systems, enabling precise, efficient...

Rare genetic disorders, which affect millions globally but lack effective treatments, represent the most immediate and impactful therapeutic application for gene editing technologies. These diseases, often caused by a single gene mutation, are ideally suited for correction using precise tools like CRISPR. Sickle Cell Disease (SCD) and Beta-Thalassemia have emerged as flagship successes,...